[
    [
        {
            "time": "2018-09-05",
            "original_text": "宜华健康两年收购医院超20家 床位数过万",
            "features": {
                "keywords": [
                    "宜华健康",
                    "收购",
                    "医院",
                    "床位数"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "宜华健康两年收购医院超20家 床位数过万",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "医疗保健：短期事件拖累表现 荐3股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "短期事件",
                    "拖累",
                    "荐股"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗保健：短期事件拖累表现 荐3股",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "复星医药跌幅已经超过20% 易方达系六基金遭“团灭”",
            "features": {
                "keywords": [
                    "复星医药",
                    "跌幅",
                    "易方达",
                    "基金"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药跌幅已经超过20% 易方达系六基金遭“团灭”",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "上半年9家药企销售费用超20亿 7家增长翻倍",
            "features": {
                "keywords": [
                    "药企",
                    "销售费用",
                    "增长翻倍"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上半年9家药企销售费用超20亿 7家增长翻倍",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "2018年医药行业中报总结分析：暂时无方向性 自下而上选择为主",
            "features": {
                "keywords": [
                    "医药行业",
                    "中报",
                    "总结分析",
                    "自下而上"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2018年医药行业中报总结分析：暂时无方向性 自下而上选择为主",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "乐视网和中弘股份停牌核查;两只养老目标基金下周一发行;金力永磁、丰山集团今日申购 | 9月6日",
            "features": {
                "keywords": [
                    "乐视网",
                    "中弘股份",
                    "停牌核查",
                    "养老目标基金",
                    "金力永磁",
                    "丰山集团"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乐视网和中弘股份停牌核查;两只养老目标基金下周一发行;金力永磁、丰山集团今日申购 | 9月6日",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "【晨会聚焦】中报分红的机遇与风险",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "中报分红",
                    "机遇",
                    "风险"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【晨会聚焦】中报分红的机遇与风险",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-09-05",
            "original_text": "【医药-复星医药(600196)】江琦、赵磊：公司点评：嫁接海外成熟产品技术，CAR-T细胞治疗取得突破 - 20180905",
            "features": {
                "keywords": [
                    "复星医药",
                    "CAR-T",
                    "细胞治疗",
                    "突破"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药-复星医药(600196)】江琦、赵磊：公司点评：嫁接海外成熟产品技术，CAR-T细胞治疗取得突破 - 20180905",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "【药讯】复星引进的全球第二款CAR-T疗法Yescarta获临床批准、华海抗VEGF单克隆抗体获临床批件",
            "features": {
                "keywords": [
                    "复星",
                    "CAR-T",
                    "Yescarta",
                    "华海",
                    "VEGF",
                    "单克隆抗体"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【药讯】复星引进的全球第二款CAR-T疗法Yescarta获临床批准、华海抗VEGF单克隆抗体获临床批件",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-06",
            "original_text": "医药行业周报:基药目录大调整,国务院下令增补187个品种",
            "features": {
                "keywords": [
                    "医药行业",
                    "基药目录",
                    "调整",
                    "增补",
                    "国务院"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报:基药目录大调整,国务院下令增补187个品种",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]